Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features von Missiaglia, E., Jacobs, B., D'Ario, G., Di Narzo, A.F., Soneson, C., Budinska, E., Popovici, V., Vecchione, L., Gerster, S., Yan, P., Roth, A.D., Klingbiel, D., Bosman, F.T., Delorenzi, M., Tejpar, S.

Volltext

Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity von Vanderbeke, L., Van Mol, P., Van Herck, Y., De Smet, F., Humblet-Baron, S., Martinod, K., Antoranz, A., Arijs, I., Boeckx, B., Bosisio, F. M., Casaer, M., Dauwe, D., De Wever, W., Dooms, C., Dreesen, E., Emmaneel, A., Filtjens, J., Gouwy, M., Gunst, J., Hermans, G., Jansen, S., Lagrou, K., Liston, A., Lorent, N., Meersseman, P., Mercier, T., Neyts, J., Odent, J., Panovska, D., Penttila, P. A., Pollet, E., Proost, P., Qian, J., Quintelier, K., Raes, J., Rex, S., Saeys, Y., Sprooten, J., Tejpar, S., Testelmans, D., Thevissen, K., Van Buyten, T., Vandenhaute, J., Van Gassen, S., Velásquez Pereira, L. C., Vos, R., Weynand, B., Wilmer, A., Yserbyt, J., Garg, A. D., Matthys, P., Wouters, C., Lambrechts, D., Wauters, E., Wauters, J.

Volltext

The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX... von Mooi, J.K., Wirapati, P., Asher, R., Lee, C.K., Savas, P., Price, T.J., Townsend, A., Hardingham, J., Buchanan, D., Williams, D., Tejpar, S., Mariadason, J.M., Tebbutt, N.C.

Volltext

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study von Dienstmann, R., Mason, M.J., Sinicrope, F.A., Phipps, A.I., Tejpar, S., Nesbakken, A., Danielsen, S.A., Sveen, A., Buchanan, D.D., Clendenning, M., Rosty, C., Bot, B., Alberts, S.R., Milburn Jessup, J., Lothe, R.A., Delorenzi, M., Newcomb, P.A., Sargent, D., Guinney, J.

Volltext

Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial von Klingbiel, D., Saridaki, Z., Roth, A.D., Bosman, F.T., Delorenzi, M., Tejpar, S.

Volltext

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer von Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J.H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., Ciardiello, F., D'Hoore, A., Diaz-Rubio, E., Douillard, J.-Y., Ducreux, M., Falcone, A., Grothey, A., Gruenberger, T., Haustermans, K., Heinemann, V., Hoff, P., Köhne, C.-H., Labianca, R., Laurent-Puig, P., Ma, B., Maughan, T., Muro, K., Normanno, N., Österlund, P., Oyen, W.J.G., Papamichael, D., Pentheroudakis, G., Pfeiffer, P., Price, T.J., Punt, C., Ricke, J., Roth, A., Salazar, R., Scheithauer, W., Schmoll, H.J., Tabernero, J., Taïeb, J., Tejpar, S., Wasan, H., Yoshino, T., Zaanan, A., Arnold, D.

Volltext

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial von Stintzing, S., Wirapati, P., Lenz, H.-J., Neureiter, D., Fischer von Weikersthal, L., Decker, T., Kiani, A., Kaiser, F., Al-Batran, S., Heintges, T., Lerchenmüller, C., Kahl, C., Seipelt, G., Kullmann, F., Moehler, M., Scheithauer, W., Held, S., Modest, D.P., Jung, A., Kirchner, T., Aderka, D., Tejpar, S., Heinemann, V.

Volltext

FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer von Bokemeyer, C, Köhne, C.-H, Ciardiello, F, Lenz, H.-J, Heinemann, V, Klinkhardt, U, Beier, F, Duecker, K, van Krieken, J.H, Tejpar, S

Volltext

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer von ROTH, Arnaud D, DELORENZI, Mauro, NORDLINGER, Bernard, BOSMAN, Fred, VAN CUTSEM, Eric, TEJPAR, Sabine, PU YAN, KLINGBIEL, Dirk, FIOCCA, Roberto, D'ARIO, Giovanni, CISAR, Laura, LABIANCA, Roberto, CUNNINGHAM, David

Volltext

Guidelines for the clinical management of familial adenomatous polyposis (FAP) von Vasen, H F A, Möslein, G, Alonso, A, Aretz, S, Bernstein, I, Bertario, L, Blanco, I, Bülow, S, Burn, J, Capella, G, Colas, C, Engel, C, Frayling, I, Friedl, W, Hes, F J, Hodgson, S, Järvinen, H, Mecklin, J-P, Møller, P, Myrhøi, T, Nagengast, F M, Parc, Y, Phillips, R, Clark, S K, de Leon, M Ponz, Renkonen-Sinisalo, L, Sampson, J R, Stormorken, A, Tejpar, S, Thomas, H J W, Wijnen, J

Volltext

PG 2.04 Systemic treatment of CRC: Molecular profiles ready for clinical practice? von Tejpar, S

Volltext

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab von De Roock, W., Piessevaux, H., De Schutter, J., Janssens, M., De Hertogh, G., Personeni, N., Biesmans, B., Van Laethem, J.-L., Peeters, M., Humblet, Y., Van Cutsem, E., Tejpar, S.

Volltext

Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis von De Smedt, L, Lemahieu, J, Palmans, S, Govaere, O, Tousseyn, T, Van Cutsem, E, Prenen, H, Tejpar, S, Spaepen, M, Matthijs, G, Decaestecker, C, Moles Lopez, X, Demetter, P, Salmon, I, Sagaert, X

Volltext

HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients von Martin, V, Landi, L, Molinari, F, Fountzilas, G, Geva, R, Riva, A, Saletti, P, De Dosso, S, Spitale, A, Tejpar, S, Kalogeras, K T, Mazzucchelli, L, Frattini, M, Cappuzzo, F

Volltext

Peutz–Jeghers syndrome: a systematic review and recommendations for management von Beggs, A D, Latchford, A R, Vasen, H F A, Moslein, G, Alonso, A, Aretz, S, Bertario, L, Blanco, I, Bülow, S, Burn, J, Capella, G, Colas, C, Friedl, W, Møller, P, Hes, F J, Järvinen, H, Mecklin, J-P, Nagengast, F M, Parc, Y, Phillips, R K S, Hyer, W, Ponz de Leon, M, Renkonen-Sinisalo, L, Sampson, J R, Stormorken, A, Tejpar, S, Thomas, H J W, Wijnen, J T, Clark, S K, Hodgson, S V

Volltext

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program von van Krieken, J. H. J. M., Jung, A., Kirchner, T., Carneiro, F., Seruca, R., Bosman, F. T., Quirke, P., Fléjou, J. F., Plato Hansen, T., de Hertogh, G., Jares, P., Langner, C., Hoefler, G., Ligtenberg, M., Tiniakos, D., Tejpar, S., Bevilacqua, G., Ensari, A.

Volltext

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Euro... von Lamarca, A., Morfouace, M., Tejpar, S., Oliveira, J., Capela, A., Penel, N., Gennigens, C., Brasiuniene, B., Peron, J., Stevovic, A., Blay, J.-Y., Klümpen, H.-J.

Volltext

Clinical and molecular characteristics and treatment outcomes of advanced right-colon, left-colon and rectal cancers: data from 1180 patients in a phase III trial of panitumumab wi... von Seligmann, J.F., Elliott, F., Richman, S., Hemmings, G., Brown, S., Jacobs, B., Williams, C., Tejpar, S., Barrett, J.H., Quirke, P., Seymour, M.

Volltext

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer von Macarulla, T, Cervantes, A, Tabernero, J, Roselló, S, Van Cutsem, E, Tejpar, S, Prenen, H, Martinelli, E, Troiani, T, Laffranchi, B, Jego, V, von Richter, O, Ciardiello, F

Volltext

Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer von Burzykowski, Tomasz, Coart, Elisabeth, Saad, Everardo D, Shi, Qian, Sommeijer, Dirkje W, Bokemeyer, Carsten, Diaz-Rubio, Eduardo, Douillard, Jean-Yves, Falcone, Alfredo, Fuchs, Charles S, Goldberg, Richard M, Hecht, J. Randolph, Hoff, Paulo M, Hurwitz, Herbert, Kabbinavar, Fairooz F, Koopman, Miriam, Maughan, Timothy S, Punt, Cornelis J.A, Saltz, Leonard, Schmoll, Hans-Joachim, Seymour, Matthew T, Tebbutt, Niall C, Tournigand, Christophe, Van Cutsem, Erik, de Gramont, Aimery, Zalcberg, John R, Buyse, Marc, Aide et Recherche en Cancerologie Digestive Group

Volltext